News
21 July 2026
Strengthening the Government’s Preventive Health Efforts, Sustainable Health Program Reaches More Than 16,500 People
JAKARTA – More than 16,500 people across Indonesia have participated in the Cek Kesehatan Segitiga, a free health screening program organized by Dexa Medica through Dharma Dexa since 2024. Beyond providing blood pressure, blood glucose, and cholesterol screenings, the program, now conducted at 22 locations, also integrates health education, medical…
14 July 2026
Supporting the National Health Program, Cek Segitiga Serves More Than 15,000 People
Surabaya – Through Dharma Dexa, Dexa Medica continues to implement Cek Segitiga, a free community health screening program that supports the Indonesian government’s efforts to strengthen the early detection of non-communicable diseases (NCDs). Since its launch in 2024, the program has reached more than 15,000 people through blood pressure, blood…
8 July 2026
OGB Merah at HISFARSI 2026: Reflecting Quality, Strengthening Trust
The quality of generic medicines can be demonstrated both through the production process and through the trust placed in them by healthcare professionals who use them in their practice. Building on this commitment, PT Dexa Medica presented "OGB Merah, A Reflection of Quality Generic Medicine" at the HISFARSI 2026 National…
5 September 2023
Dexa Medica Halal Product Guarantee System Wins Halal Award
Dexa Group once again received the Halal Award from the Lembaga Pengkajian Pangan Obat-obatan dan Kosmetika Majelis Ulama Indonesia (LPPOM MUI) in the Best Social Contribution on Halal environment category, demonstrating its dedication to establishing a halal environment in Indonesia. "I congratulate all companies and business actors nominated for and…
28 August 2023
Dexa Medica Contributes to PIT IAI, Support Advancement, and Faces Pharmaceutical Challenges
Dexa Medica participated in the Annual Scientific Meeting (PIT) of the Ikatan Apoteker Indonesia (IAI) in Solo City, Central Java, on August 24 -26, 2023, as a form of collaboration in supporting advancement and facing challenges in the pharmaceutical and health fields in accordance with the Dexa Medica's core purpose,…
23 August 2023
BKKBN and Dexa Medica Educate Blitar Midwife on The Importance of Breast Milk in Overcoming Stunting
In the 2024 Rancangan Anggaran Belanja dan Pendapatan Negara (RAPBN), President Joko Widodo allotted IDR 186.4 trillion, or 5.6 percent, towards the healthcare system. One of the primary goals is to reduce the prevalence of stunting in Indonesia by 14 percent by 2024. In this context, Hasto Wardoyo, the Head…
27 June 2023
Commitment to Accelerate Stunting Reduction Prevalence to 14%, Dexa Medica and BKKBN Educate Thousand of Midwives
Various parties are involved in the pentahelix collaboration to pursue the stunting reduction target of 14% by 2024. To continue pursuinh the stunting reduction target set by President Joko Widodo, the National Population and Family Planning Agency (BKKBN) collaborated with Dexa Medica and the South Sumatra Provincial Government to hold…
1 June 2023
Contributing to Nation’s Health, Dexa Group Receives 2023 CSR Awards
Dexa Group's Dexa Award Science Scholarship program won an award in the healthcare and consumer category at the B-Universe CSR Awards. The award organized by B-Universe has the theme "Maximizing Shared Value Through Sustainable CSR Initiatives". The realization of this CSR Awards award was initiated from the message that President…
22 May 2023
Dexa Group, BKKBN, Polri, and IBI Collaborate to Achieve Target to Reduce Stunting Rate to 14% by 2024
The 2022 Indonesian Nutritional Status Survey (SSGI) shows that the national prevalence of stunting has decreased to by 2.8% to 21.6% compared to the previous year. Dexa Group collaborates with the National Population and Family Planning Board (BKKBN), the Indonesian National Police (Polri), and the Regional Government (Pemda) of Wonosobo…